The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 26, 2024
Filed:
Aug. 29, 2022
Applicant:
Inimmune Corporation, Missoula, MT (US);
Inventors:
Helene Bazin-Lee, Stevensville, MT (US);
George Ettenger, Missoula, MT (US);
Juhienah Khalaf, Hamilton, MT (US);
Kendal T. Ryter, Hamilton, MT (US);
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 31/04 (2006.01); A61K 31/7008 (2006.01); A61K 39/00 (2006.01); A61K 39/35 (2006.01); A61K 39/39 (2006.01); A61K 45/06 (2006.01); A61P 9/10 (2006.01); A61P 11/02 (2006.01); A61P 17/04 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); C07H 15/12 (2006.01); C07H 15/26 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7008 (2013.01); A61K 39/35 (2013.01); A61K 39/39 (2013.01); A61P 9/10 (2018.01); A61P 11/02 (2018.01); A61P 17/04 (2018.01); A61P 31/04 (2018.01); A61P 35/00 (2018.01); A61P 37/00 (2018.01); C07H 15/12 (2013.01); C07H 15/26 (2013.01); A61K 2039/57 (2013.01); A61K 45/06 (2013.01);
Abstract
Toll-like receptor (TLR) ligands having an allose-based core are stable in aqueous formulation and are useful in treating, preventing, or reducing susceptibility to diseases or conditions mediated by TLRs, such as cancer, infectious disease, allergy, autoimmune disease, sepsis, and ischemia reperfusion.